首页 | 本学科首页   官方微博 | 高级检索  
     


The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment
Authors:Hossein Poustchi  Sara Majd Jabbari  Shahin Merat  Amir-Houshang Sharifi  Ali Akbar Shayesteh  Elahe Shayesteh  Mohammad Minakari  Mohammad Reza Fattahi  Maryam Moini  Fatemeh Roozbeh  Fariborz Mansour-Ghanaei  Behrooz Afshar  Marjan Mokhtare  Taghi Amiriani  Masoomeh Sofian  Mohammad-Hossein Somi  Shahram Agah  Iradj Maleki  Maryam Latifnia  Mojtaba Fattahi Abdizadeh  Ahmad Hormati  Masoud Khoshnia  Masoudreza Sohrabi  Zeinab Malekzadeh  Dorsa Merat  Reza Malekzadeh
Affiliation:1. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran;2. Alimentary Tract Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran;3. Department of Gastroenterology 4. and Hepatology, Isfahan University of Medical Sciences, Isfahan, Iran;5. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;6. Department of Gastroenterology and Hepatology, Mazandaran University of Medical Sciences, Sari, Iran;7. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran;8. Department of Gastroenterology and Hepatology, Hamadan University of Medical Sciences, Hamadan, Iran;9. Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran;10. Golestan Research Center for Gastroenterology and Hepatology, Golestan University of Medical Science, Gorgan, Iran;11. Infectious Disease Research Center, Arak University of Medical Science, Arak, Iran;12. Department of Gastroenterology and Hepatology, Tabriz University of Medical Sciences, Tabriz, Iran;13. Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran;14. Department of Gastroenterology and Hepatology, Sabzevar University of Medical Sciences, Sabzevar, Iran;15. Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran;16. Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Science, Qom, Iran;17. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Golestan Research Center for Gastroenterology and Hepatology, Golestan University of Medical Science, Gorgan, Iran;18. Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran

Abstract:
Keywords:Hepatitis C  renal insufficiency  sofosbuvir  daclatasvir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号